S'abonner

Pediatric Urinary Stone Disease in the United States: The Urologic Diseases in America Project - 28/07/19

Doi : 10.1016/j.urology.2019.04.012 
Julia B. Ward a, b, Lydia Feinstein a, b, , Casey Pierce a, John Lim a, Kevin C. Abbott c, Tamara Bavendam c, Ziya Kirkali c, Brian R. Matlaga d

The NIDDK Urologic Diseases in America Project

a Social and Scientific Systems, Durham, NC 
b Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 
c National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 
d Johns Hopkins University School of Medicine, Baltimore, MD 

Address correspondence to: Lydia B. Feinstein, Ph.D., Social and Scientific Systems, 4505 Emperor Boulevard, Suite 400, Durham, NC 27703.Social and Scientific Systems4505 Emperor Boulevard, Suite 400DurhamNC27703

Abstract

Objective

To examine the recent epidemiology of pediatric urinary stone disease (USD) in the United States.

Methods

We utilized the 2004-2016 Optum© Clinformatics® Data Mart database, a de-identified adjudicated administrative health claims database that includes 15-18 million individuals covered annually by commercial insurance in all 50 US states. The analysis included 12,739,125 children aged 0-18 years. We calculated annual rates of USD, ambulatory visits, and procedures, and the prevalence of prescription fills.

Results

The 2005-2016 USD rate was 59.5 cases per 100,000 person-years. The annual rate rose gradually from 2005 to a peak of 65.2 cases per 100,000 person-years in 2011. The USD rate increased with increasing age, and was highest among females compared to males, non-Hispanic Whites compared to other race/ethnic groups, and those residing in the South compared to other geographic regions. The overall 2005-2016 rate in the 120 days following a USD episode was 1.9 for ambulatory visits, 0.24 for surgical procedures, and 1.1 for imaging procedures. Ureteroscopy was the most common surgical procedure and CT scan was the most common imaging procedures, although ultrasound utilization increased over time. Medications were filled in 46.9% of cases, and use was lowest among males (43.1%), Asians (34.8%), and in the Northeast (34.3%). Opiate agonists were the most prevalent prescription (39.9%).

Conclusion

Our study provides one of the most comprehensive examinations of pediatric USD to date, demonstrating shifting rates and treatment patterns over time, as well as differences by age, gender, race/ethnicity, and geographic region.

Le texte complet de cet article est disponible en PDF.

Plan


 The Urological Diseases in America project was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) through a contract to Social & Scientific Systems (HHSN276201500204U). Dr. Julia Ward and Dr. Lydia Feinstein are employed by Social & Scientific Systems, and Dr. Brian Matlaga of John's Hopkins University has a subcontract with the company. Dr. Matlaga also serves as a consultant for Boston Scientific.


© 2019  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 129

P. 180-187 - juillet 2019 Retour au numéro
Article précédent Article précédent
  • Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
  • Zhangqun Ye, Jian Huang, Liqun Zhou, Shan Chen, Zengjun Wang, Lulin Ma, Dongfang Wang, Gongxian Wang, Shusheng Wang, Chaozhao Liang, Shaopeng Qiu, Xiaojian Gu, Jianhe Liu, Zhiliang Weng, Changli Wu, Qiang Wei, Liping Xie, Weizhen Wu, Yue Cheng, Jingqian Hu, Zhixian Wang, Xiaoyong Zeng
| Article suivant Article suivant
  • The Incidence and Durability of Compensatory Hypertrophy in Pediatric Patients with Solitary Kidneys
  • Mary Katie Wang, Thomas Gaither, Andrew Phelps, Ronald Cohen, Laurence Baskin

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.